✦ LIBER ✦

Re: A Placebo-Controlled Study Investigating the Efficacy and Safety of the Phosphodiesterase Type 5 Inhibitor UK-369,003 for the Treatment of Men With Lower Urinary Tract Symptoms Associated With Clinical Benign Prostatic Hyperplasia

✍ Scribed by Kaplan, Steven A.

Book ID: 118483964
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 107 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2011.09.107

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled study investigating

A placebo-controlled study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with lower urinary tract symptoms associated with clinical benign prostatic hyperplasia

✍ Nihad A.M. Tamimi; Ivan Mincik; Scott Haughie; Janice Lamb; Anna Crossland; Pete 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

A placebo-controlled exploratory study i

A placebo-controlled exploratory study investigating the efficacy and safety of the phosphodiesterase type 5 inhibitor UK-369,003 for the treatment of men with storage lower urinary tract symptoms associated with a clinical diagnosis of overactive bladder

✍ Francois A. Giuliano; Janice Lamb; Anna Crossland; Scott Haughie; Peter Ellis; N 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Long-term Safety and Efficacy of Tamsulo

Long-term Safety and Efficacy of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

✍ NARAYAN, PERINCHERY; EVANS, CHRISTOPHER P.; MOON, TIMOTHY 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 424 KB

Efficacy and safety of once-daily alfuzo

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial

✍ Claus G Roehrborn 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 125 KB

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIB

EFFECT OF PHOSPHODIESTERASE TYPE 5 INHIBITOR USE ON LOWER URINARY TRACT SYMPTOMS IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (BPH): RESULTS FROM THE BPH REGISTRY

✍ Rosen, Raymond C; Wei, John T; Miner, Martin; Roehrborn, Claus G; Seftel, Allen 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 162 KB

Re: The Prostatic Urethral Lift for the

Re: The Prostatic Urethral Lift for the Treatment of Lower Urinary Tract Symptoms Associated with Prostate Enlargement Due to Benign Prostatic Hyperplasia: The L.I.F.T. Study

✍ Mavuduru, Ravimohan S.; Devana, Sudheer K.; Nayak, Brushabhanu; Gupta, Saurabh; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 60 KB